In the early stage, M1-type macrophages can produce antigen-presenting molecules and activate type I T cells, produce a large number of inflammatory factors, activate immunogenic CD8+ T lymphocytes and natural killer cells, and produce strong anti-tumor effects [55,56]. This evidence concerns the gene CD8A and neoplasm.